The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global CKD and ESRD Treatment Market Research Report 2025

Global CKD and ESRD Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1686528

No of Pages : 97

Ask Your Query
Synopsis
If left untreated, CKD can progress to kidney failure and early cardiovascular disease. When the kidneys stop working, dialysis or kidney transplant is needed for survival. Kidney failure treated with dialysis or kidney transplant is called end-stage renal disease (ESRD).
The global CKD and ESRD Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for CKD and ESRD Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CKD and ESRD Treatment.
Report Scope
The CKD and ESRD Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CKD and ESRD Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CKD and ESRD Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Nikkiso
WEGO
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
AstraZeneca
Vifor Pharma
Segment by Type
Medicine
Hemodialysis
Peritoneal Dialysis
Kidney Transplantation
Segment by Application
Hospitals
Kidney Dialysis Centers
At Homes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CKD and ESRD Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CKD and ESRD Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medicine
1.2.3 Hemodialysis
1.2.4 Peritoneal Dialysis
1.2.5 Kidney Transplantation
1.3 Market by Application
1.3.1 Global CKD and ESRD Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Kidney Dialysis Centers
1.3.4 At Homes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CKD and ESRD Treatment Market Perspective (2019-2030)
2.2 CKD and ESRD Treatment Growth Trends by Region
2.2.1 Global CKD and ESRD Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CKD and ESRD Treatment Historic Market Size by Region (2019-2024)
2.2.3 CKD and ESRD Treatment Forecasted Market Size by Region (2025-2030)
2.3 CKD and ESRD Treatment Market Dynamics
2.3.1 CKD and ESRD Treatment Industry Trends
2.3.2 CKD and ESRD Treatment Market Drivers
2.3.3 CKD and ESRD Treatment Market Challenges
2.3.4 CKD and ESRD Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CKD and ESRD Treatment Players by Revenue
3.1.1 Global Top CKD and ESRD Treatment Players by Revenue (2019-2024)
3.1.2 Global CKD and ESRD Treatment Revenue Market Share by Players (2019-2024)
3.2 Global CKD and ESRD Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CKD and ESRD Treatment Revenue
3.4 Global CKD and ESRD Treatment Market Concentration Ratio
3.4.1 Global CKD and ESRD Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CKD and ESRD Treatment Revenue in 2023
3.5 CKD and ESRD Treatment Key Players Head office and Area Served
3.6 Key Players CKD and ESRD Treatment Product Solution and Service
3.7 Date of Enter into CKD and ESRD Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CKD and ESRD Treatment Breakdown Data by Type
4.1 Global CKD and ESRD Treatment Historic Market Size by Type (2019-2024)
4.2 Global CKD and ESRD Treatment Forecasted Market Size by Type (2025-2030)
5 CKD and ESRD Treatment Breakdown Data by Application
5.1 Global CKD and ESRD Treatment Historic Market Size by Application (2019-2024)
5.2 Global CKD and ESRD Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CKD and ESRD Treatment Market Size (2019-2030)
6.2 North America CKD and ESRD Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CKD and ESRD Treatment Market Size by Country (2019-2024)
6.4 North America CKD and ESRD Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CKD and ESRD Treatment Market Size (2019-2030)
7.2 Europe CKD and ESRD Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CKD and ESRD Treatment Market Size by Country (2019-2024)
7.4 Europe CKD and ESRD Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CKD and ESRD Treatment Market Size (2019-2030)
8.2 Asia-Pacific CKD and ESRD Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CKD and ESRD Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific CKD and ESRD Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CKD and ESRD Treatment Market Size (2019-2030)
9.2 Latin America CKD and ESRD Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CKD and ESRD Treatment Market Size by Country (2019-2024)
9.4 Latin America CKD and ESRD Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CKD and ESRD Treatment Market Size (2019-2030)
10.2 Middle East & Africa CKD and ESRD Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CKD and ESRD Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa CKD and ESRD Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fresenius
11.1.1 Fresenius Company Detail
11.1.2 Fresenius Business Overview
11.1.3 Fresenius CKD and ESRD Treatment Introduction
11.1.4 Fresenius Revenue in CKD and ESRD Treatment Business (2019-2024)
11.1.5 Fresenius Recent Development
11.2 DaVita
11.2.1 DaVita Company Detail
11.2.2 DaVita Business Overview
11.2.3 DaVita CKD and ESRD Treatment Introduction
11.2.4 DaVita Revenue in CKD and ESRD Treatment Business (2019-2024)
11.2.5 DaVita Recent Development
11.3 Baxter
11.3.1 Baxter Company Detail
11.3.2 Baxter Business Overview
11.3.3 Baxter CKD and ESRD Treatment Introduction
11.3.4 Baxter Revenue in CKD and ESRD Treatment Business (2019-2024)
11.3.5 Baxter Recent Development
11.4 Nipro
11.4.1 Nipro Company Detail
11.4.2 Nipro Business Overview
11.4.3 Nipro CKD and ESRD Treatment Introduction
11.4.4 Nipro Revenue in CKD and ESRD Treatment Business (2019-2024)
11.4.5 Nipro Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Detail
11.5.2 B. Braun Business Overview
11.5.3 B. Braun CKD and ESRD Treatment Introduction
11.5.4 B. Braun Revenue in CKD and ESRD Treatment Business (2019-2024)
11.5.5 B. Braun Recent Development
11.6 Asahi Kasei
11.6.1 Asahi Kasei Company Detail
11.6.2 Asahi Kasei Business Overview
11.6.3 Asahi Kasei CKD and ESRD Treatment Introduction
11.6.4 Asahi Kasei Revenue in CKD and ESRD Treatment Business (2019-2024)
11.6.5 Asahi Kasei Recent Development
11.7 Nikkiso
11.7.1 Nikkiso Company Detail
11.7.2 Nikkiso Business Overview
11.7.3 Nikkiso CKD and ESRD Treatment Introduction
11.7.4 Nikkiso Revenue in CKD and ESRD Treatment Business (2019-2024)
11.7.5 Nikkiso Recent Development
11.8 WEGO
11.8.1 WEGO Company Detail
11.8.2 WEGO Business Overview
11.8.3 WEGO CKD and ESRD Treatment Introduction
11.8.4 WEGO Revenue in CKD and ESRD Treatment Business (2019-2024)
11.8.5 WEGO Recent Development
11.9 Newsol
11.9.1 Newsol Company Detail
11.9.2 Newsol Business Overview
11.9.3 Newsol CKD and ESRD Treatment Introduction
11.9.4 Newsol Revenue in CKD and ESRD Treatment Business (2019-2024)
11.9.5 Newsol Recent Development
11.10 Mayo Clinic
11.10.1 Mayo Clinic Company Detail
11.10.2 Mayo Clinic Business Overview
11.10.3 Mayo Clinic CKD and ESRD Treatment Introduction
11.10.4 Mayo Clinic Revenue in CKD and ESRD Treatment Business (2019-2024)
11.10.5 Mayo Clinic Recent Development
11.11 Guangdong Biolight
11.11.1 Guangdong Biolight Company Detail
11.11.2 Guangdong Biolight Business Overview
11.11.3 Guangdong Biolight CKD and ESRD Treatment Introduction
11.11.4 Guangdong Biolight Revenue in CKD and ESRD Treatment Business (2019-2024)
11.11.5 Guangdong Biolight Recent Development
11.12 Medtronic
11.12.1 Medtronic Company Detail
11.12.2 Medtronic Business Overview
11.12.3 Medtronic CKD and ESRD Treatment Introduction
11.12.4 Medtronic Revenue in CKD and ESRD Treatment Business (2019-2024)
11.12.5 Medtronic Recent Development
11.13 Sanxin Medtec
11.13.1 Sanxin Medtec Company Detail
11.13.2 Sanxin Medtec Business Overview
11.13.3 Sanxin Medtec CKD and ESRD Treatment Introduction
11.13.4 Sanxin Medtec Revenue in CKD and ESRD Treatment Business (2019-2024)
11.13.5 Sanxin Medtec Recent Development
11.14 Jafron Biomedical
11.14.1 Jafron Biomedical Company Detail
11.14.2 Jafron Biomedical Business Overview
11.14.3 Jafron Biomedical CKD and ESRD Treatment Introduction
11.14.4 Jafron Biomedical Revenue in CKD and ESRD Treatment Business (2019-2024)
11.14.5 Jafron Biomedical Recent Development
11.15 SWS Hemodialysis Care
11.15.1 SWS Hemodialysis Care Company Detail
11.15.2 SWS Hemodialysis Care Business Overview
11.15.3 SWS Hemodialysis Care CKD and ESRD Treatment Introduction
11.15.4 SWS Hemodialysis Care Revenue in CKD and ESRD Treatment Business (2019-2024)
11.15.5 SWS Hemodialysis Care Recent Development
11.16 Tianyi Medical
11.16.1 Tianyi Medical Company Detail
11.16.2 Tianyi Medical Business Overview
11.16.3 Tianyi Medical CKD and ESRD Treatment Introduction
11.16.4 Tianyi Medical Revenue in CKD and ESRD Treatment Business (2019-2024)
11.16.5 Tianyi Medical Recent Development
11.17 AstraZeneca
11.17.1 AstraZeneca Company Detail
11.17.2 AstraZeneca Business Overview
11.17.3 AstraZeneca CKD and ESRD Treatment Introduction
11.17.4 AstraZeneca Revenue in CKD and ESRD Treatment Business (2019-2024)
11.17.5 AstraZeneca Recent Development
11.18 Vifor Pharma
11.18.1 Vifor Pharma Company Detail
11.18.2 Vifor Pharma Business Overview
11.18.3 Vifor Pharma CKD and ESRD Treatment Introduction
11.18.4 Vifor Pharma Revenue in CKD and ESRD Treatment Business (2019-2024)
11.18.5 Vifor Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global CKD and ESRD Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Medicine
Table 3. Key Players of Hemodialysis
Table 4. Key Players of Peritoneal Dialysis
Table 5. Key Players of Kidney Transplantation
Table 6. Global CKD and ESRD Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global CKD and ESRD Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global CKD and ESRD Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global CKD and ESRD Treatment Market Share by Region (2019-2024)
Table 10. Global CKD and ESRD Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global CKD and ESRD Treatment Market Share by Region (2025-2030)
Table 12. CKD and ESRD Treatment Market Trends
Table 13. CKD and ESRD Treatment Market Drivers
Table 14. CKD and ESRD Treatment Market Challenges
Table 15. CKD and ESRD Treatment Market Restraints
Table 16. Global CKD and ESRD Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global CKD and ESRD Treatment Market Share by Players (2019-2024)
Table 18. Global Top CKD and ESRD Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CKD and ESRD Treatment as of 2023)
Table 19. Ranking of Global Top CKD and ESRD Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by CKD and ESRD Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players CKD and ESRD Treatment Product Solution and Service
Table 23. Date of Enter into CKD and ESRD Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global CKD and ESRD Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global CKD and ESRD Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global CKD and ESRD Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global CKD and ESRD Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global CKD and ESRD Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global CKD and ESRD Treatment Revenue Market Share by Application (2019-2024)
Table 31. Global CKD and ESRD Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global CKD and ESRD Treatment Revenue Market Share by Application (2025-2030)
Table 33. North America CKD and ESRD Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America CKD and ESRD Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America CKD and ESRD Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe CKD and ESRD Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe CKD and ESRD Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe CKD and ESRD Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific CKD and ESRD Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific CKD and ESRD Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific CKD and ESRD Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America CKD and ESRD Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America CKD and ESRD Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America CKD and ESRD Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa CKD and ESRD Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa CKD and ESRD Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa CKD and ESRD Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. Fresenius Company Detail
Table 49. Fresenius Business Overview
Table 50. Fresenius CKD and ESRD Treatment Product
Table 51. Fresenius Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 52. Fresenius Recent Development
Table 53. DaVita Company Detail
Table 54. DaVita Business Overview
Table 55. DaVita CKD and ESRD Treatment Product
Table 56. DaVita Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 57. DaVita Recent Development
Table 58. Baxter Company Detail
Table 59. Baxter Business Overview
Table 60. Baxter CKD and ESRD Treatment Product
Table 61. Baxter Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 62. Baxter Recent Development
Table 63. Nipro Company Detail
Table 64. Nipro Business Overview
Table 65. Nipro CKD and ESRD Treatment Product
Table 66. Nipro Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 67. Nipro Recent Development
Table 68. B. Braun Company Detail
Table 69. B. Braun Business Overview
Table 70. B. Braun CKD and ESRD Treatment Product
Table 71. B. Braun Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 72. B. Braun Recent Development
Table 73. Asahi Kasei Company Detail
Table 74. Asahi Kasei Business Overview
Table 75. Asahi Kasei CKD and ESRD Treatment Product
Table 76. Asahi Kasei Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 77. Asahi Kasei Recent Development
Table 78. Nikkiso Company Detail
Table 79. Nikkiso Business Overview
Table 80. Nikkiso CKD and ESRD Treatment Product
Table 81. Nikkiso Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 82. Nikkiso Recent Development
Table 83. WEGO Company Detail
Table 84. WEGO Business Overview
Table 85. WEGO CKD and ESRD Treatment Product
Table 86. WEGO Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 87. WEGO Recent Development
Table 88. Newsol Company Detail
Table 89. Newsol Business Overview
Table 90. Newsol CKD and ESRD Treatment Product
Table 91. Newsol Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 92. Newsol Recent Development
Table 93. Mayo Clinic Company Detail
Table 94. Mayo Clinic Business Overview
Table 95. Mayo Clinic CKD and ESRD Treatment Product
Table 96. Mayo Clinic Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 97. Mayo Clinic Recent Development
Table 98. Guangdong Biolight Company Detail
Table 99. Guangdong Biolight Business Overview
Table 100. Guangdong Biolight CKD and ESRD Treatment Product
Table 101. Guangdong Biolight Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 102. Guangdong Biolight Recent Development
Table 103. Medtronic Company Detail
Table 104. Medtronic Business Overview
Table 105. Medtronic CKD and ESRD Treatment Product
Table 106. Medtronic Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 107. Medtronic Recent Development
Table 108. Sanxin Medtec Company Detail
Table 109. Sanxin Medtec Business Overview
Table 110. Sanxin Medtec CKD and ESRD Treatment Product
Table 111. Sanxin Medtec Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 112. Sanxin Medtec Recent Development
Table 113. Jafron Biomedical Company Detail
Table 114. Jafron Biomedical Business Overview
Table 115. Jafron Biomedical CKD and ESRD Treatment Product
Table 116. Jafron Biomedical Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 117. Jafron Biomedical Recent Development
Table 118. SWS Hemodialysis Care Company Detail
Table 119. SWS Hemodialysis Care Business Overview
Table 120. SWS Hemodialysis Care CKD and ESRD Treatment Product
Table 121. SWS Hemodialysis Care Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 122. SWS Hemodialysis Care Recent Development
Table 123. Tianyi Medical Company Detail
Table 124. Tianyi Medical Business Overview
Table 125. Tianyi Medical CKD and ESRD Treatment Product
Table 126. Tianyi Medical Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 127. Tianyi Medical Recent Development
Table 128. AstraZeneca Company Detail
Table 129. AstraZeneca Business Overview
Table 130. AstraZeneca CKD and ESRD Treatment Product
Table 131. AstraZeneca Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 132. AstraZeneca Recent Development
Table 133. Vifor Pharma Company Detail
Table 134. Vifor Pharma Business Overview
Table 135. Vifor Pharma CKD and ESRD Treatment Product
Table 136. Vifor Pharma Revenue in CKD and ESRD Treatment Business (2019-2024) & (US$ Million)
Table 137. Vifor Pharma Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CKD and ESRD Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global CKD and ESRD Treatment Market Share by Type: 2023 VS 2030
Figure 3. Medicine Features
Figure 4. Hemodialysis Features
Figure 5. Peritoneal Dialysis Features
Figure 6. Kidney Transplantation Features
Figure 7. Global CKD and ESRD Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global CKD and ESRD Treatment Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Kidney Dialysis Centers Case Studies
Figure 11. At Homes Case Studies
Figure 12. Others Case Studies
Figure 13. CKD and ESRD Treatment Report Years Considered
Figure 14. Global CKD and ESRD Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global CKD and ESRD Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global CKD and ESRD Treatment Market Share by Region: 2023 VS 2030
Figure 17. Global CKD and ESRD Treatment Market Share by Players in 2023
Figure 18. Global Top CKD and ESRD Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CKD and ESRD Treatment as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by CKD and ESRD Treatment Revenue in 2023
Figure 20. North America CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America CKD and ESRD Treatment Market Share by Country (2019-2030)
Figure 22. United States CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe CKD and ESRD Treatment Market Share by Country (2019-2030)
Figure 26. Germany CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific CKD and ESRD Treatment Market Share by Region (2019-2030)
Figure 34. China CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America CKD and ESRD Treatment Market Share by Country (2019-2030)
Figure 42. Mexico CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa CKD and ESRD Treatment Market Share by Country (2019-2030)
Figure 46. Turkey CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia CKD and ESRD Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Fresenius Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 49. DaVita Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 50. Baxter Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 51. Nipro Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 52. B. Braun Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 53. Asahi Kasei Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 54. Nikkiso Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 55. WEGO Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 56. Newsol Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 57. Mayo Clinic Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 58. Guangdong Biolight Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 59. Medtronic Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 60. Sanxin Medtec Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 61. Jafron Biomedical Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 62. SWS Hemodialysis Care Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 63. Tianyi Medical Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 64. AstraZeneca Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 65. Vifor Pharma Revenue Growth Rate in CKD and ESRD Treatment Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock